JGC
CHAC.U

J. Goldman & Co’s Chardan Healthcare Acquisition Corp. CHAC.U Stock Holding History

J. Goldman & Co’s Portfolio CHAC.U Stock Details CHAC.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-150,000
Closed -$1.53M – 419
2019
Q2 		$1.53M Hold
150,000
– – 0.11% 171
2019
Q1 		$1.5M Hold
150,000
– – 0.08% 181
2018
Q4 		$1.51M Buy
+150,000
New +$1.5M 0.12% 161

Other funds holding CHAC.U

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
RA
Rational Advisors Huntington, New York $1.09B AUM 11.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

J. Goldman & Co's CHAC.U Position: Q3 2019 in Review

J. Goldman & Co sold out of Chardan Healthcare Acquisition Corp. (CHAC.U) in Q3 2019, closing a stake of 150,000 shares — an estimated $1.53M sold.

J. Goldman & Co first reported a position in CHAC.U in Q4 2018 and held it in 3 quarters. The position peaked at $1.53M in Q2 2019. 8 funds tracked by Wall St. Rank hold CHAC.U as of Q3 2019.

  • J. Goldman & Co reported no remaining Chardan Healthcare Acquisition Corp. position as of Q3 2019 after selling out during the quarter.
  • J. Goldman & Co sold 150,000 Chardan Healthcare Acquisition Corp. shares in Q3 2019, an estimated $1.53M.
  • J. Goldman & Co first reported a position in Chardan Healthcare Acquisition Corp. in Q4 2018 and held it in 3 quarters.
  • J. Goldman & Co's Chardan Healthcare Acquisition Corp. position peaked at $1.53M in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition Corp. as of Q3 2019.

Based on J. Goldman & Co's 13F filing for Q3 2019, filed 14 Nov 2019.